Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$19.50 -0.66 (-3.27%)
At close: Sep 22, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Other Non-Current Liabilities (2017 - 2026)

Amneal Pharmaceuticals (AMRX) posted Other Non-Current Liabilities of $70.8 million for Q2 2026, up 1.16% on a QoQ basis from $70.0 million in Q1 2026, and down 4.9% year-over-year from $74.5 million in Q2 2025.

Analysis

Amneal Pharmaceuticals (AMRX) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Amneal Pharmaceuticals has reported Other Non-Current Liabilities for 10 years, with the latest figure at $70.8 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 4.9% year-over-year to $70.8 million in Q2 2026; TTM through Jun 2026 was $70.8 million, a 4.9% decrease from a year earlier, with the FY2025 full-year figure at $71.8 million, down 15.98% from the prior year.
  • Other Non-Current Liabilities was $70.8 million for Q2 2026 at Amneal Pharmaceuticals, up from $70.0 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $87.5 million in Q4 2022, with the low at $316000.0 in Q4 2023.
  • Average Other Non-Current Liabilities over 5 years is $65.4 million, with a median of $73.7 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities slumped 99.64% in 2023, then jumped 26950.32% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $87.5 million in 2022, then plunged by 99.64% to $316000.0 in 2023, then surged by 26950.32% to $85.5 million in 2024, then decreased by 15.98% to $71.8 million in 2025, then slipped by 1.38% to $70.8 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $70.8 million (Q2 2026), $70.0 million (Q1 2026), and $71.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.83 Mn
Mar 31, 2026 70.02 Mn
Dec 31, 2025 71.82 Mn
Sep 30, 2025 74.48 Mn
Jun 30, 2025 74.48 Mn
Mar 31, 2025 72.98 Mn
Dec 31, 2024 85.48 Mn
Sep 30, 2024 85.48 Mn
Jun 30, 2024 85.48 Mn
Mar 31, 2024 85.48 Mn
Dec 31, 2023 316,000.00
Sep 30, 2023 41.39 Mn
Jun 30, 2023 39.28 Mn
Mar 31, 2023 41.46 Mn
Dec 31, 2022 87.47 Mn
Sep 30, 2022 78.26 Mn
Jun 30, 2022 79.21 Mn
Mar 31, 2022 32.87 Mn
Dec 31, 2021 38.90 Mn
Sep 30, 2021 60.80 Mn
API Access

Amneal Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AMRX&period=max&api_key=YOUR_API_KEY